Neuroleptic malignant syndrome.

dc.contributor.authorBhattacharyya, Ken_US
dc.date.accessioned1999-09-25en_US
dc.date.accessioned2009-05-30T18:50:47Z
dc.date.available1999-09-25en_US
dc.date.available2009-05-30T18:50:47Z
dc.date.issued1999-09-25en_US
dc.identifier.citationBhattacharyya K. Neuroleptic malignant syndrome. Journal of the Association of Physicians of India. 1999 Sep; 47(9): 940en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/86222
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAntipsychotic Agents --administration & dosageen_US
dc.subject.meshHumansen_US
dc.subject.meshNeuroleptic Malignant Syndrome --diagnosisen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshSchizophrenia --drug therapyen_US
dc.titleNeuroleptic malignant syndrome.en_US
dc.typeCommenten_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: